Bisantrene in advanced, hormone-resistant carcinoma of the prostate: an Illinois Cancer Council phase II study.
N J Vogelzang, V J Lanzotti, B Muntean, R R Blough
Index: Invest. New Drugs 8(3) , 313-5, (1990)
Full Text: HTML
Abstract
Related Compounds
Related Articles:
In vitro effects of bisantrene on fresh clonogenic leukemia cells: a preliminary study on 15 cases.
1990-01-01
[Haematologica 75(6) , 527-31, (1990)]
Phase II trial of Bisantrene for metastatic melanoma: an Illinois cancer council study.
1991-01-01
[Med. Pediatr. Oncol. 19(2) , 126-8, (1991)]
Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.
2014-04-29
[Clin. Cancer Res. 2(6) , 973-80, (1996)]
1998-01-20
[Bioorg. Med. Chem. Lett. 8(2) , 121-6, (1998)]
Bisantrene in relapsed and refractory acute myelogenous leukemia.
1993-02-01
[Leuk. Lymphoma 9(3) , 217-20, (1993)]